Welcome to LookChem.com Sign In|Join Free

CAS

  • or

367-31-7

Post Buying Request

367-31-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

367-31-7 Usage

Description

3,4-Diaminofluorobenzene, also known as 4-Fluoro-o-phenylenediamine, is an organic compound characterized by its white to brown powder form. It is a derivative of aniline, with fluorine and amino groups attached to the benzene ring at the 3 and 4 positions, respectively. 3,4-Diaminofluorobenzene is known for its chemical reactivity and is commonly utilized as a building block in the synthesis of various pharmaceuticals and other specialty chemicals.

Uses

Used in Pharmaceutical Industry:
3,4-Diaminofluorobenzene is used as a pharmaceutical intermediate for the synthesis of various drugs and medications. Its unique chemical structure allows it to be a versatile component in the development of new pharmaceutical compounds, contributing to the advancement of medical treatments.
Used in Chemical Synthesis:
In addition to its pharmaceutical applications, 3,4-Diaminofluorobenzene is also used as a key intermediate in the synthesis of various specialty chemicals. Its reactivity and functional groups make it a valuable component in the production of dyes, pigments, and other chemical products.
Used in Research and Development:
Due to its unique chemical properties, 3,4-Diaminofluorobenzene is often employed in research and development settings. Scientists and researchers use this compound to study its reactivity, explore new synthetic pathways, and develop novel applications in various industries, including pharmaceuticals, materials science, and chemical engineering.

Check Digit Verification of cas no

The CAS Registry Mumber 367-31-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,6 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 367-31:
(5*3)+(4*6)+(3*7)+(2*3)+(1*1)=67
67 % 10 = 7
So 367-31-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H7FN2/c7-4-1-2-5(8)6(9)3-4/h1-3H,8-9H2

367-31-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A13977)  4-Fluoro-o-phenylenediamine, 97%   

  • 367-31-7

  • 5g

  • 805.0CNY

  • Detail
  • Alfa Aesar

  • (A13977)  4-Fluoro-o-phenylenediamine, 97%   

  • 367-31-7

  • 25g

  • 3599.0CNY

  • Detail
  • Alfa Aesar

  • (A13977)  4-Fluoro-o-phenylenediamine, 97%   

  • 367-31-7

  • 100g

  • 11889.0CNY

  • Detail

367-31-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Fluorobenzene-1,2-diamine

1.2 Other means of identification

Product number -
Other names 4-fluorobenzene-1,2-diamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:367-31-7 SDS

367-31-7Relevant articles and documents

Synthesis and anticonvulsant properties of 2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]benzimidazol-1-one derivatives.

Chimirri,De Sarro,De Sarro,Gitto,Zappala

, p. 821 - 826 (2001)

A number of novel 1H-pyrrolo[1,2-a]benzimidazol-1-one derivatives were prepared and their anticonvulsant properties evaluated. The new synthesized compounds proved to possess anticonvulsant effects depending on the nature of substituents at C-6, C-2, and C-3a positions of the polycyclic system. In particular, the 6-chloro-3a-(p-tolyl)-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]benzimidazol-1-one derivative (22) displayed potency fivefold higher than unsubstituted compound (13).

Regioselective Radical Arene Amination for the Concise Synthesis ofortho-Phenylenediamines

Gillespie, James E.,Morrill, Charlotte,Phipps, Robert J.

supporting information, p. 9355 - 9360 (2021/07/19)

The formation of arene C-N bonds directly from C-H bonds is of great importance and there has been rapid recent development of methods for achieving this through radical mechanisms, often involving reactiveN-centered radicals. A major challenge associated with these advances is that of regiocontrol, with mixtures of regioisomeric products obtained in most protocols, limiting broader utility. We have designed a system that utilizes attractive noncovalent interactions between an anionic substrate and an incoming radical cation in order to guide the latter to the areneorthoposition. The anionic substrate takes the form of a sulfamate-protected aniline and telescoped cleavage of the sulfamate group after amination leads directly toortho-phenylenediamines, key building blocks for a range of medicinally relevant diazoles. Our method can deliver both free amines and monoalkyl amines allowing access to unsymmetrical, selectively monoalkylated benzimidazoles and benzotriazoles. As well as providing concise access to valuableortho-phenylenediamines, this work demonstrates the potential for utilizing noncovalent interactions to control positional selectivity in radical reactions.

From methylene bridged diindole to carbonyl linked benzimidazoleindole: Development of potent and metabolically stable PCSK9 modulators

Xie, Haibo,Yang, Ka,Winston-McPherson, Gabrielle N.,Stapleton, Donnie S.,Keller, Mark P.,Attie, Alan D.,Smith, Kerry A.,Tang, Weiping

, (2020/08/21)

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a recently validated therapeutic target for lowering low-density lipoprotein cholesterol (LDL-C). Through phenotypic screening, we previously discovered a class of small-molecules with a 2,3′-diindolymethane (DIM) skeleton that can decrease the expression of PCSK9. But these compounds have low potency and low metabolically stability. After performing structure-activity relationship (SAR) optimization by nitrogen scan, deuterium substitution and fluorine scan, we identified a series of much more potent and metabolically stable PCSK9 modulators. A preliminary in vivo pharmacokinetic study was performed for representative analogues difluorodiindolyketone (DFDIK) 12 and difluorobenzoimidazolylindolylketone (DFBIIK-1) 13. The in vitro metabolic stability correlate well with the in vivo data. The most potent compound 21 has the EC50 of 0.15 nM. Our SAR studies also indicated that the NH on the indole ring of 21 can tolerate more function groups, which may facilitate the mechanism of action studies and also allow further improvement of the pharmacological properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 367-31-7